George A. Scangos is the former CEO of Biogen, where he served from July 2010 to July 2016. He advanced the company significantly during his tenure, focusing on biotechnology innovations and strategic growth. Before joining Biogen, he had notable experience...
George A. Scangos is the former CEO of Biogen, where he served from July 2010 to July 2016. He advanced the company significantly during his tenure, focusing on biotechnology innovations and strategic growth. Before joining Biogen, he had notable experience leading Exelixis, a biotech firm, where he spent over a decade. His background includes holding high-ranking positions, like President of Biotechnology at Bayer Corporation, which showcases his deep understanding of the biotech landscape. Under his leadership, Biogen's revenue and earnings per share consistently surpassed targets, reflecting his effectiveness in steering the company towards success. That said, Scangos did not begin his career in biotechnology; his Ph.D. in microbiology brought a scientific edge to his executive decisions. Interesting to note, in 2010, he started with a solid $1.2 million salary and benefited from long-term incentive stock grants that have seen fluctuations, including more than $6 million in vested stock over his time at Biogen. His insight into market strategies and performance metrics has helped Biogen become a key player in the biotechnology industry.